Senior insider sale
Chief Commercial Officer at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$3.06M
20.63K shares
What this filing means
KHAYAL TAMER I plans to sell 20.63K shares of TRANSMEDICS GROUP, INC. valued at approximately $3.06M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/1/2024ACC: 0001968582-24-000649
Officer· Chief Commercial Officer
Since May 2019
20.63K
Shares to sell
$3.06M
Approx. market value
8.88K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/1/2024
8.88KTotal acquired8.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/1/2024 | Stock Option Exercise Cash | 8.88K | — |
| Total | 8.88K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
2.96K
Market value
$447.9K
7/1/2024
—Completed
Units to sell
2.96K
Market value
$394.0K
6/3/2024
—Completed
Units to sell
5.84K
Market value
$759.5K
5/6/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
8.88K
Market value
$1.45M
8/1/2024
Total
Units
20.63K
Value
$3.06M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2024 | 2.96K | $447.9K | — | Completed |
6/3/2024 | 2.96K | $394.0K | — | Completed |
5/6/2024 | 5.84K | $759.5K | — | Completed |
| Planned — Approximate Date | ||||
8/1/2024 | 8.88K | $1.45M | Nasdaq | Planned |
| Total | 20.63K | $3.06M | ||